Showing results (1131-1140 of 1,274) with videos related to

Sort By:
Pageof 128
Multiple Sclerosis and Related Disorders|August 6, 2026
Long-term safety and efficacy of ponesimod, an oral S1P1 receptor modulator, in relapsing-remitting multiple sclerosis (RRMS): Results from randomized phase 2b core and extension studies spanning up to 13 yearsTomas Olsson, Xavier Montalban, Reinhard Hohlfeld, et al.
Neurology|August 19, 2011
Interferon β-1b-neutralizing antibodies 5 years after clinically isolated syndromeH-P Hartung, M S Freedman, C H Polman, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 21, 2011
Predictive nature of IgM anti-α-glucose serum biomarker for relapse activity and EDSS progression in CIS patients: a BENEFIT study analysisM S Freedman, C Metzig, L Kappos, et al.
American Journal of Epidemiology|April 13, 2017
Evaluation of the 24-Hour Recall as a Reference Instrument for Calibrating Other Self-Report Instruments in Nutritional Cohort Studies: Evidence From the Validation Studies Pooling ProjectLaurence S Freedman, John M Commins, Walter Willett, et al.
Cancer Research|March 17, 2006
Common cancer biomarkersChristopher F Basil, Yingdong Zhao, Katia Zavaglia, et al.
Therapeutic Advances in Neurological Disorders|September 25, 2023
Safety and efficacy with alemtuzumab over 13 years in relapsing-remitting multiple sclerosis: final results from the open-label TOPAZ studyAlasdair J Coles, Anat Achiron, Anthony Traboulsee, et al.
Annals of Clinical and Translational Neurology|October 7, 2014
Molecular mechanism underlying the impact of vitamin D on disease activity of MSKassandra L Munger, Karl Köchert, Kelly C Simon, et al.
American Journal of Epidemiology|December 18, 2001
Design and serendipity in establishing a large cohort with wide dietary intake distributions : the National Institutes of Health-American Association of Retired Persons Diet and Health StudyA Schatzkin, A F Subar, F E Thompson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Phase I study of intraperitoneal recombinant human interleukin 12 in patients with Müllerian carcinoma, gastrointestinal primary malignancies, and mesotheliomaRenato Lenzi, Michael Rosenblum, Claire Verschraegen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 16, 2013
Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trialPatrick Vermersch, Anna Czlonkowska, Luigi M E Grimaldi, et al.
Pageof 128